GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Float Percentage Of Total Shares Outstanding

Read-Gene (WAR:RDG) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jul. 22, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Read-Gene's float shares is 0.00 Mil. Read-Gene's total shares outstanding is 11.79 Mil. Read-Gene's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Read-Gene's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Read-Gene's Institutional Ownership is 0.00%.

Read-Gene Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Read-Gene's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/11.79
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Read-Gene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
WAR:URT WAR:PHR WAR:NNG WAR:GX1 WAR:PUR WAR:SCS WAR:MOC WAR:RNT WAR:PTG WAR:MAB VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003
Website
http://www.read-gene.com
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene Headlines

No Headlines